Blood Pressure and Arterial Load after Transcatheter Aortic Valve Replacement for Aortic Stenosis

Circulation: Cardiovascular Imaging

Volumn 10, Issue 7, 2017, Pages

  Lindman, Brian R ^a,b   Otto, Catherine M ^c   Douglas, Pamela S ^d   Hahn, Rebecca T ^e   Elmariah, Sammy ^f   Weissman, Neil J ^g   Stewart, William J ^h   Ayele, Girma M ⁱ   Zhang, Feifan ⁱ   Zajarias, Alan ^b   Maniar, Hersh S ^b   Jilaihawi, Hasan ^j   Blackstone, Eugene ^h   Chinnakondepalli, Khaja M ^k   Tuzcu, E Murat ^h   Leon, Martin B ^e,i   Pibarot, Philippe ^l  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

^e Department of Medicine   (United States)

^f MASSACHUSETTS GENERAL HOSPITAL   (United States)

^g GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h LERNER RESEARCH INSTITUTE   (United States)

ⁱ CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

^j CEDARS SINAI MEDICAL CENTER   (United States)

^k SAINT LUKE S MID AMERICA HEART INSTITUTE   (United States)

^l UNIVERSITÉ LAVAL   (Canada)

more..

Author keywords

aortic valve stenosis; blood pressure; heart valve prosthesis; mortality; transcatheter aortic valve replacement

Indexed keywords

ADVERSE EFFECTS; AGED; AORTIC VALVE; AORTIC VALVE STENOSIS; ARTERIAL PRESSURE; CLINICAL TRIAL; CLINICAL TRIAL (TOPIC); DIAGNOSTIC IMAGING; DOPPLER ECHOCARDIOGRAPHY; FEMALE; HUMAN; KAPLAN MEIER METHOD; MALE; MORTALITY; MULTICENTER STUDY; NORTH AMERICA; PATHOPHYSIOLOGY; PROPORTIONAL HAZARDS MODEL; PULSATILE FLOW; REGISTER; RETROSPECTIVE STUDY; RISK FACTOR; SEVERITY OF ILLNESS INDEX; TIME FACTOR; TRANSCATHETER AORTIC VALVE IMPLANTATION; TREATMENT OUTCOME; VASCULAR RESISTANCE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AORTIC VALVE; AORTIC VALVE STENOSIS; ARTERIAL PRESSURE; CLINICAL TRIALS AS TOPIC; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; NORTH AMERICA; PROPORTIONAL HAZARDS MODELS; PULSATILE FLOW; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TRANSCATHETER AORTIC VALVE REPLACEMENT; TREATMENT OUTCOME; VASCULAR RESISTANCE;

EID: 85026305039     PISSN: 19419651     EISSN: 19420080     Source Type: Journal    
DOI: 10.1161/CIRCIMAGING.116.006308     Document Type: Article

References (41)

1. Ross J Jr, Braunwald E. Aortic stenosis. Circulation. 1968;38(1 suppl):61-67.
2. Cohn JN, Franciosa JA. Vasodilator therapy of cardiac failure (second of two parts). N Engl J Med. 1977;297:254-258. doi: 10.1056/NEJM197708042970506.
3. Khot UN, Novaro GM, Popović ZB, Mills RM, Thomas JD, Tuzcu EM, Hammer D, Nissen SE, Francis GS. Nitroprusside in critically ill patients with left ventricular dysfunction and aortic stenosis. N Engl J Med. 2003;348:1756-1763. doi: 10.1056/NEJMoa022021.
4. Lindman BR, Zajarias A, Madrazo JA, Shah J, Gage BF, Novak E, Johnson SN, Chakinala MM, Hohn TA, Saghir M, Mann DL. Effects of phosphodiesterase type 5 inhibition on systemic and pulmonary hemodynamics and ventricular function in patients with severe symptomatic aortic stenosis. Circulation. 2012;125:2353-2362. doi: 10.1161/CIRCULATIONAHA.111.081125.
5. Carabello BA. Georg Ohm and the changing character of aortic stenosis: it's not your grandfather's oldsmobile. Circulation. 2012;125:2295-2297. doi: 10.1161/CIRCULATIONAHA.112.105825.
6. Lindman BR, Otto CM. Time to treat hypertension in patients with aortic stenosis. Circulation. 2013;128:1281-1283. doi: 10.1161/CIRCULATIONAHA.113.005275.
7. Adams DH, Popma JJ, Reardon MJ, Yakubov SJ, Coselli JS, Deeb GM, Gleason TG, Buchbinder M, Hermiller J Jr, Kleiman NS, Chetcuti S, Heiser J, Merhi W, Zorn G, Tadros P, Robinson N, Petrossian G, Hughes GC, Harrison JK, Conte J, Maini B, Mumtaz M, Chenoweth S, Oh JK; U.S. CoreValve Clinical Investigators. Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med. 2014;370:1790-1798. doi: 10.1056/NEJMoa1400590.
8. Rodés-Cabau J, Webb JG, Cheung A, Ye J, Dumont E, Feindel CM, Osten M, Natarajan MK, Velianou JL, Martucci G, DeVarennes B, Chisholm R, Peterson MD, Lichtenstein SV, Nietlispach F, Doyle D, DeLarochellière R, Teoh K, Chu V, Dancea A, Lachapelle K, Cheema A, Latter D, Horlick E. Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience. J Am Coll Cardiol. 2010;55:1080-1090. doi: 10.1016/j.jacc.2009.12.014.
9. Briand M, Dumesnil JG, Kadem L, Tongue AG, Rieu R, Garcia D, Pibarot P. Reduced systemic arterial compliance impacts significantly on left ventricular afterload and function in aortic stenosis: implications for diagnosis and treatment. J Am Coll Cardiol. 2005;46:291-298. doi: 10.1016/j.jacc.2004.10.081.
10. Hachicha Z, Dumesnil JG, Pibarot P. Usefulness of the valvuloarterial impedance to predict adverse outcome in asymptomatic aortic stenosis. J Am Coll Cardiol. 2009;54:1003-1011. doi: 10.1016/j.jacc.2009.04.079.
11. Rieck ?E, Cramariuc D, Boman K, Gohlke-Bärwolf C, Staal EM, Lønnebakken MT, Rossebø AB, Gerdts E. Hypertension in aortic stenosis: implications for left ventricular structure and cardiovascular events. Hypertension. 2012;60:90-97. doi: 10.1161/HYPERTENSIONAHA.112.194878.
12. Nielsen OW, Sajadieh A, Sabbah M, Greve AM, Olsen MH, Boman K, Nienaber CA, Kesäniemi YA, Pedersen TR, Willenheimer R, Wachtell K. Assessing optimal blood pressure in patients with asymptomatic aortic valve stenosis: the Simvastatin Ezetimibe in Aortic Stenosis Study (SEAS). Circulation. 2016;134:455-468. doi: 10.1161/CIRCULATIONAHA.115.021213.
13. O'Gara PT. Management of hypertension in patients with mild to moderate aortic stenosis: navigating the SEAS. Circulation. 2016;134:469-471. doi: 10.1161/CIRCULATIONAHA.116.023688.
14. Wright JT Jr, Williamson JD, Whelton PK, Snyder JK, Sink KM, Rocco MV, Reboussin DM, Rahman M, Oparil S, Lewis CE, Kimmel PL, Johnson KC, Goff DC Jr, Fine LJ, Cutler JA, Cushman WC, Cheung AK, Ambrosius WT; SPRINT Research Group. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med. 2015;373:2103-2116. doi: 10.1056/NEJMoa1511939.
15. Williamson JD, Supiano MA, Applegate WB, Berlowitz DR, Campbell RC, Chertow GM, Fine LJ, Haley WE, Hawfield AT, Ix JH, Kitzman DW, Kostis JB, Krousel-Wood MA, Launer LJ, Oparil S, Rodriguez CJ, Roumie CL, Shorr RI, Sink KM, Wadley VG, Whelton PK, Whittle J, Woolard NF, Wright JT Jr, Pajewski NM; SPRINT Research Group. Intensive vs standard blood pressure control and cardiovascular disease outcomes in adults aged ≥75 years: a randomized clinical trial. JAMA. 2016;315:2673-2682. doi: 10.1001/jama.2016.7050.
16. Ettehad D, Emdin CA, Kiran A, Anderson SG, Callender T, Emberson J, Chalmers J, Rodgers A, Rahimi K. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet. 2016;387:957-967. doi: 10.1016/S0140-6736(15)01225-8.
17. Pibarot P, Weissman NJ, Stewart WJ, Hahn RT, Lindman BR, McAndrew T, Kodali SK, Mack MJ, Thourani VH, Miller DC, Svensson LG, Herrmann HC, Smith CR, Rodés-Cabau J, Webb J, Lim S, Xu K, Hueter I, Douglas PS, Leon MB. Incidence and sequelae of prosthesis-patient mismatch in transcatheter versus surgical valve replacement in high-risk patients with severe aortic stenosis: a PARTNER trial cohort-a analysis. J Am Coll Cardiol. 2014;64:1323-1334. doi: 10.1016/j.jacc.2014.06.1195.
18. Daneshvar SA, Rahimtoola SH. Valve prosthesis-patient mismatch (VPPM): a long-term perspective. J Am Coll Cardiol. 2012;60:1123-1135. doi: 10.1016/j.jacc.2012.05.035.
19. Yotti R, Bermejo J, Gutiérrez-Ibañes E, Pérez del Villar C, Mombiela T, Elízaga J, Benito Y, González-Mansilla A, Barrio A, Rodríguez-Pérez D, Martínez-Legazpi P, Fernández-Avilés F. Systemic vascular load in calcific degenerative aortic valve stenosis: insight from percutaneous valve replacement. J Am Coll Cardiol. 2015;65:423-433. doi: 10.1016/j.jacc.2014.10.067.
20. Laskey WK, Kussmaul WG, Martin JL, Kleaveland JP, Hirshfeld JW Jr, Shroff S. Characteristics of vascular hydraulic load in patients with heart failure. Circulation. 1985;72:61-71.
21. Chirinos JA, Segers P. Noninvasive evaluation of left ventricular afterload: part 1: pressure and flow measurements and basic principles of wave conduction and reflection. Hypertension. 2010;56:555-562. doi: 10.1161/HYPERTENSIONAHA.110.157321.
22. Chirinos JA, Segers P. Noninvasive evaluation of left ventricular afterload: part 2: arterial pressure-flow and pressure-volume relations in humans. Hypertension. 2010;56:563-570. doi: 10.1161/HYPERTENSIONAHA.110.157339.
23. Perlman GY, Loncar S, Pollak A, Gilon D, Alcalai R, Planer D, Lotan C, Danenberg HD. Post-procedural hypertension following transcatheter aortic valve implantation: incidence and clinical significance. JACC Cardiovasc Interv. 2013;6:472-478. doi: 10.1016/j.jcin.2012.12.124.
24. Reinthaler M, Stähli BE, Gopalamurugan AB, Xiu PY, Aggarwal SK, Fröhlich G, Delahunty N, Mullen MJ. Post-procedural arterial hypertension: implications for clinical outcome after transcatheter aortic valve implantation. J Heart Valve Dis. 2014;23:675-682.
25. Laskey WK, Kussmaul WG 3rd. Hypertension, aortic valve stenosis, and the aorta: more lessons from TAVR. J Am Coll Cardiol. 2015;65:434-436. doi: 10.1016/j.jacc.2014.11.029.
26. Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Brown DL, Block PC, Guyton RA, Pichard AD, Bavaria JE, Herrmann HC, Douglas PS, Petersen JL, Akin JJ, Anderson WN, Wang D, Pocock S; PARTNER Trial Investigators. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363:1597-1607. doi: 10.1056/NEJMoa1008232.
27. Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Williams M, Dewey T, Kapadia S, Babaliaros V, Thourani VH, Corso P, Pichard AD, Bavaria JE, Herrmann HC, Akin JJ, Anderson WN, Wang D, Pocock SJ; PARTNER Trial Investigators. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364:2187-2198. doi: 10.1056/NEJMoa1103510.
28. Douglas PS, Waugh RA, Bloomfield G, Dunn G, Davis L, Hahn RT, Pibarot P, Stewart WJ, Weissman NJ, Hueter I, Siegel R, Lerakis S, Miller DC, Smith CR, Leon MB. Implementation of echocardiography core laboratory best practices: a case study of the PARTNER I trial. J Am Soc Echocardiogr. 2013;26:348-358.e3. doi: 10.1016/j.echo.2013.01.013.
29. Kelly RP, Ting CT, Yang TM, Liu CP, Maughan WL, Chang MS, Kass DA. Effective arterial elastance as index of arterial vascular load in humans. Circulation. 1992;86:513-521.
30. Chemla D, Hébert JL, Coirault C, Zamani K, Suard I, Colin P, Lecarpentier Y. Total arterial compliance estimated by stroke volume-to-aortic pulse pressure ratio in humans. Am J Physiol. 1998;274(2 pt 2):H500-H505.
31. Makkar RR, Fontana G, Jilaihawi H, Chakravarty T, Kofoed KF, de Backer O, Asch FM, Ruiz CE, Olsen NT, Trento A, Friedman J, Berman D, Cheng W, Kashif M, Jelnin V, Kliger CA, Guo H, Pichard AD, Weissman NJ, Kapadia S, Manasse E, Bhatt DL, Leon MB, Søndergaard L. Possible subclinical leaflet thrombosis in bioprosthetic aortic valves. N Engl J Med. 2015;373:2015-2024. doi: 10.1056/NEJMoa1509233.
32. Benetos A, Gautier S, Labat C, Salvi P, Valbusa F, Marino F, Toulza O, Agnoletti D, Zamboni M, Dubail D, Manckoundia P, Rolland Y, Hanon O, Perret-Guillaume C, Lacolley P, Safar ME, Guillemin F. Mortality and cardiovascular events are best predicted by low central/peripheral pulse pressure amplification but not by high blood pressure levels in elderly nursing home subjects: the PARTAGE (Predictive Values of Blood Pressure and Arterial Stiffness in Institutionalized Very Aged Population) study. J Am Coll Cardiol. 2012;60:1503-1511. doi: 10.1016/j.jacc.2012.04.055.
33. Oates DJ, Berlowitz DR, Glickman ME, Silliman RA, Borzecki AM. Blood pressure and survival in the oldest old. J Am Geriatr Soc. 2007;55:383-388. doi: 10.1111/j.1532-5415.2007.01069.x.
34. Molander L, Lövheim H, Norman T, Nordström P, Gustafson Y. Lower systolic blood pressure is associated with greater mortality in people aged 85 and older. J Am Geriatr Soc. 2008;56:1853-1859. doi: 10.1111/j.1532-5415.2008.01948.x.
35. Zamani P, Bluemke DA, Jacobs DR Jr, Duprez DA, Kronmal R, Lilly SM, Ferrari VA, Townsend RR, Lima JA, Budoff M, Segers P, Hannan P, Chirinos JA. Resistive and pulsatile arterial load as predictors of left ventricular mass and geometry: the multi-ethnic study of atherosclerosis. Hypertension. 2015;65:85-92. doi: 10.1161/HYPERTENSIONAHA.114.04333.
36. de Simone G, Roman MJ, Koren MJ, Mensah GA, Ganau A, Devereux RB. Stroke volume/pulse pressure ratio and cardiovascular risk in arterial hypertension. Hypertension. 1999;33:800-805.
37. Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol. 2010;55:1318-1327. doi: 10.1016/j.jacc.2009.10.061.
38. Laurent S, Boutouyrie P, Asmar R, Gautier I, Laloux B, Guize L, Ducimetiere P, Benetos A. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension. 2001;37:1236-1241.
39. Zieman SJ, Melenovsky V, Kass DA. Mechanisms, pathophysiology, and therapy of arterial stiffness. Arterioscler Thromb Vasc Biol. 2005;25:932-943. doi: 10.1161/01.ATV.0000160548.78317.29.
40. Kass DA, Shapiro EP, Kawaguchi M, Capriotti AR, Scuteri A, deGroof RC, Lakatta EG. Improved arterial compliance by a novel advanced glycation end-product crosslink breaker. Circulation. 2001;104:1464-1470.
41. Yotti R, Bermejo J, Gutiérrez-Ibañes E, Pérez Del Villar C, Mombiela T, Elízaga J, Benito Y, González-Mansilla A, Barrio A, Rodríguez-Pérez D, Martínez-Legazpi P, Fernández-Avilés F. Reply: aortic stiffness: complex evaluation but major prognostic significance before TAVR. J Am Coll Cardiol. 2015;66:1522-1523. doi: 10.1016/j.jacc.2015.07.043.